Senseonics Holdings (SENS) Tops Q2 EPS by 6c

Go back to Senseonics Holdings (SENS) Tops Q2 EPS by 6c

Senseonics Holdings (SENS) Announces Positive Coverage Decision for Eversense CGM from Highmark Inc.

August 7, 2020 8:01 AM EDT

Senseonics Holdings, Inc. (NYSE: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced Highmark Inc. will begin providing coverage for the Eversense CGM effective September 28, 2020. This coverage decision... More